_id
6919eb3f3c536f8df2318366
Ticker
MHC.LSE
Name
MyHealthChecked Plc
Exchange
LSE
Address
The Maltings, Cardiff, United Kingdom, CF24 5EA
Country
UK
Sector
Financial Services
Industry
Shell Companies
Currency
GBX
Website
https://myhealthchecked.com
Description
MyHealthChecked PLC develops, distributes, and commercializes at-home healthcare and wellness tests in the United Kingdom. The company offers general health and energy profile blood test, bowel health rapid test, and stomach ulcer rapid test; nutritional health tests, such as intolerances and sensitivities DNA tests, vitamins and minerals DNA and profile blood tests, iron deficiency rapid test, and vitamin D rapid test; and weight management tests that includes weight management DNA and blood tests, glucose management DNA tests, and thyroid profile blood test and stimulating hormone rapid test. It also provides cardiovascular health tests, such as heart profile blood and heart profile test; women's health tests comprising female sexual health test, polycystic ovary syndrome blood test, and menopause profile blood test; and men's health products, including erectile dysfunction blood test, male sexual health test, and sperm concentration rapid test. The company was formerly known as Concepta PLC and changed its name to MyHealthChecked PLC in December 2020. MyHealthChecked PLC was incorporated in 2008 and is based in Cardiff, the United Kingdom.
Last Close
9.25
Volume
84856
Current Price
9.25
Change
0.5
Last Updated
2025-11-26T09:04:21.941Z
Image
https://logo.clearbit.com/myhealthchecked.com
Ipo Date
-
Market Cap
4683234
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
494000
Cost Of Revenue
893000
Gross Profit
-399000
Operating Expenses
973000
Operating Income
-1372000
Interest Expense
-
Pretax Income
-1356000
Net Income
-1356000
Eps
-0.02615144413153783
Dividends Per Share
-
Shares Outstanding
52035932
Income Tax Expense
-
EBITDA
-1229000
Operating Margin
-277.7327935222672
Total Other Income Expense Net
16000
Cash
5058000
Short Term Investments
-
Receivables
1909000
Inventories
100000
Total Current Assets
7067000
Property Plant Equipment
52000
Total Assets
8415000
Payables
2781000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
2781000
Equity
5634000
Depreciation
127000
Change In Working Capital
839000
Cash From Operations
-375000
Capital Expenditures
0
Cash From Investing
-40000
Cash From Financing
-
Net Change In Cash
-415000
PE
-
PB
85.13122901135961
ROE
-24.068157614483493
ROA
-16.114081996434937
FCF
-375000
Fcf Percent
-0.7591093117408907
Piotroski FScore
1
Health Score
27
Deep Value Investing Score
5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.3
Garp Investing Score
2.5
Growth Investing Score
1
Momentum Investing Score
4.5
Net Net Investing Score
5
Quality Investing Score
3
Value Investing Score
5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
494000
Quarters > 0 > income Statement > cost Of Revenue
893000
Quarters > 0 > income Statement > gross Profit
-399000
Quarters > 0 > income Statement > operating Expenses
973000
Quarters > 0 > income Statement > operating Income
-1372000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-1356000
Quarters > 0 > income Statement > net Income
-1356000
Quarters > 0 > income Statement > eps
-0.02615144413153783
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
51851821
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-1229000
Quarters > 0 > income Statement > operating Margin
-277.7327935222672
Quarters > 0 > income Statement > total Other Income Expense Net
16000
Quarters > 0 > balance Sheet > cash
5058000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
1909000
Quarters > 0 > balance Sheet > inventories
100000
Quarters > 0 > balance Sheet > total Current Assets
7067000
Quarters > 0 > balance Sheet > property Plant Equipment
52000
Quarters > 0 > balance Sheet > total Assets
8415000
Quarters > 0 > balance Sheet > payables
2781000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
2781000
Quarters > 0 > balance Sheet > equity
5634000
Quarters > 0 > cash Flow > net Income
-1356000
Quarters > 0 > cash Flow > depreciation
127000
Quarters > 0 > cash Flow > change In Working Capital
839000
Quarters > 0 > cash Flow > cash From Operations
-375000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-40000
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-415000
Quarters > 0 > ratios > PE
-0.02615144413153783
Quarters > 0 > ratios > PB
85.13122901135961
Quarters > 0 > ratios > ROE
-24.068157614483493
Quarters > 0 > ratios > ROA
-16.114081996434937
Quarters > 0 > ratios > FCF
-375000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-0.7591093117408907
Quarters > 0 > health Score
27
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
2726000
Quarters > 1 > income Statement > cost Of Revenue
2765000
Quarters > 1 > income Statement > gross Profit
-38999
Quarters > 1 > income Statement > operating Expenses
843000
Quarters > 1 > income Statement > operating Income
-882000
Quarters > 1 > income Statement > interest Expense
1000
Quarters > 1 > income Statement > pretax Income
-587000
Quarters > 1 > income Statement > net Income
-587000
Quarters > 1 > income Statement > eps
-0.011326673596584137
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
51824571
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-456000
Quarters > 1 > income Statement > operating Margin
-32.35509904622157
Quarters > 1 > income Statement > total Other Income Expense Net
295000
Quarters > 1 > balance Sheet > cash
5473000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
1761000
Quarters > 1 > balance Sheet > inventories
133000
Quarters > 1 > balance Sheet > total Current Assets
7367000
Quarters > 1 > balance Sheet > property Plant Equipment
82000
Quarters > 1 > balance Sheet > total Assets
8802000
Quarters > 1 > balance Sheet > payables
795000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
1827000
Quarters > 1 > balance Sheet > equity
6975000
Quarters > 1 > cash Flow > net Income
-587000
Quarters > 1 > cash Flow > depreciation
131000
Quarters > 1 > cash Flow > change In Working Capital
-83000
Quarters > 1 > cash Flow > cash From Operations
-524000
Quarters > 1 > cash Flow > capital Expenditures
17000
Quarters > 1 > cash Flow > cash From Investing
-42000
Quarters > 1 > cash Flow > cash From Financing
-9000
Quarters > 1 > cash Flow > net Change In Cash
-575000
Quarters > 1 > ratios > PE
-0.011326673596584137
Quarters > 1 > ratios > PB
68.72792569892472
Quarters > 1 > ratios > ROE
-8.415770609318997
Quarters > 1 > ratios > ROA
-6.668938877527834
Quarters > 1 > ratios > FCF
-541000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-0.19845928099779897
Quarters > 1 > health Score
27
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
881000
Quarters > 2 > income Statement > cost Of Revenue
1167000
Quarters > 2 > income Statement > gross Profit
-286000
Quarters > 2 > income Statement > operating Expenses
1062000
Quarters > 2 > income Statement > operating Income
-1348000
Quarters > 2 > income Statement > interest Expense
2000
Quarters > 2 > income Statement > pretax Income
-1199000
Quarters > 2 > income Statement > net Income
-1199000
Quarters > 2 > income Statement > eps
-0.023136971585772718
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
51821821
Quarters > 2 > income Statement > income Tax Expense
150000
Quarters > 2 > income Statement > EBITDA
-1074000
Quarters > 2 > income Statement > operating Margin
-153.00794551645856
Quarters > 2 > income Statement > total Other Income Expense Net
149000
Quarters > 2 > balance Sheet > cash
6048000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
161000
Quarters > 2 > balance Sheet > inventories
339000
Quarters > 2 > balance Sheet > total Current Assets
6548000
Quarters > 2 > balance Sheet > property Plant Equipment
103000
Quarters > 2 > balance Sheet > total Assets
8071000
Quarters > 2 > balance Sheet > payables
524000
Quarters > 2 > balance Sheet > short Term Debt
24000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
536000
Quarters > 2 > balance Sheet > equity
7535000
Quarters > 2 > cash Flow > net Income
-1199000
Quarters > 2 > cash Flow > depreciation
124000
Quarters > 2 > cash Flow > change In Working Capital
-586000
Quarters > 2 > cash Flow > cash From Operations
-1636000
Quarters > 2 > cash Flow > capital Expenditures
14000
Quarters > 2 > cash Flow > cash From Investing
-51000
Quarters > 2 > cash Flow > cash From Financing
-14000
Quarters > 2 > cash Flow > net Change In Cash
-1701000
Quarters > 2 > ratios > PE
-0.023136971585772718
Quarters > 2 > ratios > PB
63.61670129396151
Quarters > 2 > ratios > ROE
-15.912408759124089
Quarters > 2 > ratios > ROA
-14.855656052533764
Quarters > 2 > ratios > FCF
-1650000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-1.872871736662883
Quarters > 2 > health Score
26
Quarters > 3 > quarter
2024-03-31
Quarters > 3 > income Statement > revenue
440500
Quarters > 3 > income Statement > cost Of Revenue
583500
Quarters > 3 > income Statement > gross Profit
-143000
Quarters > 3 > income Statement > operating Expenses
531000
Quarters > 3 > income Statement > operating Income
-674000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-599500
Quarters > 3 > income Statement > net Income
-599500
Quarters > 3 > income Statement > eps
-0.011568485792886359
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
51821821
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-612000
Quarters > 3 > income Statement > operating Margin
-153.00794551645856
Quarters > 3 > income Statement > total Other Income Expense Net
74500
Quarters > 3 > balance Sheet > cash
6048000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
161000
Quarters > 3 > balance Sheet > inventories
339000
Quarters > 3 > balance Sheet > total Current Assets
6548000
Quarters > 3 > balance Sheet > property Plant Equipment
103000
Quarters > 3 > balance Sheet > total Assets
8071000
Quarters > 3 > balance Sheet > payables
524000
Quarters > 3 > balance Sheet > short Term Debt
12000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
536000
Quarters > 3 > balance Sheet > equity
7535000
Quarters > 3 > cash Flow > net Income
-599500
Quarters > 3 > cash Flow > depreciation
62000
Quarters > 3 > cash Flow > change In Working Capital
1751000
Quarters > 3 > cash Flow > cash From Operations
-818000
Quarters > 3 > cash Flow > capital Expenditures
7000
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-7000
Quarters > 3 > cash Flow > net Change In Cash
-850500
Quarters > 3 > ratios > PE
-0.011568485792886359
Quarters > 3 > ratios > PB
63.61670129396151
Quarters > 3 > ratios > ROE
-7.9562043795620445
Quarters > 3 > ratios > ROA
-7.427828026266882
Quarters > 3 > ratios > FCF
-825000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-1.872871736662883
Quarters > 3 > health Score
26
Valuation > metrics > PE
-0.02615144413153783
Valuation > metrics > PB
85.13122901135961
Valuation > final Score
20
Valuation > verdict
2737.7% Overvalued
Profitability > metrics > ROE
-24.068157614483493
Profitability > metrics > ROA
-19.187774161596153
Profitability > metrics > Net Margin
-2.7449392712550607
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.4936102236421725
Risk > metrics > Interest Coverage
-10.803149606299213
Risk > final Score
17
Risk > verdict
High
Liquidity > metrics > Current Ratio
2.5411722402013663
Liquidity > metrics > Quick Ratio
2.5052139518158936
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-3468
Prev Risks > 1
-2636
Prev Risks > 2
-156
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:02:44.516Z
MyHealthChecked PLC develops, distributes, and commercializes at-home healthcare and wellness tests in the United Kingdom. The company offers general health and energy profile blood test, bowel health rapid test, and stomach ulcer rapid test; nutritional health tests, such as intolerances and sensitivities DNA tests, vitamins and minerals DNA and profile blood tests, iron deficiency rapid test, and vitamin D rapid test; and weight management tests that includes weight management DNA and blood tests, glucose management DNA tests, and thyroid profile blood test and stimulating hormone rapid test. It also provides cardiovascular health tests, such as heart profile blood and heart profile test; women's health tests comprising female sexual health test, polycystic ovary syndrome blood test, and menopause profile blood test; and men's health products, including erectile dysfunction blood test, male sexual health test, and sperm concentration rapid test. The company was formerly known as Concepta PLC and changed its name to MyHealthChecked PLC in December 2020. MyHealthChecked PLC was incorporated in 2008 and is based in Cardiff, the United Kingdom.
Stock Price
GBp 0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of MyHealthChecked Plc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
£ 0
Cost Of Revenue
£ 0
Gross Profit
£ 0
Operating Expenses
£ 0
Operating Income
£ 0
Interest Expense
£ 0
Pretax Income
£ 0
Net Income
£ 0
Income Tax Expense
£ 0
EBITDA
£ 0
Total Other Income Expense Net
£ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
£ 0
Short Term Investments
£ 0
Receivables
£ 0
Inventories
£ 0
Total Current Assets
£ 0
Property Plant Equipment
£ 0
Total Assets
£ 0
Payables
£ 0
Short Term Debt
£ 0
Long Term Debt
£ 0
Total Liabilities
£ 0
Equity
£ 0
(Last Updated 2025-06-30)
Net Income
£ 0
Depreciation
£ 0
Change In Working Capital
£ 0
Cash From Operations
£ 0
Capital Expenditures
£ 0
Cash From Investing
£ 0
Cash From Financing
£ 0
Net Change In Cash
£ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.